TERT and melanoma: In patients with nonacral cutaneous and spitzoid melanomas, the TERT promoter mutation was independently associated with poorer OS [50,53], whereas Nagore et al. failed to show the mutation as an independent prognostic factor in patients with primary melanoma [120].